ChemicalBook > CAS DataBase List > Pirtobrutinib

Pirtobrutinib

Product Name
Pirtobrutinib
CAS No.
2101700-15-4
Chemical Name
Pirtobrutinib
Synonyms
Pirtobrutinib;Pirtobrutinib (LOXO-305);loxo-305;LY 3527727;BTK inhibitor 16;Florfenicol Impurity 16;Pirtobrutinib, 10 mM in DMSO;LOXO-305,LY 3527727,Pirtobrutinib;(S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide;1H-Pyrazole-4-carboxamide, 5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(1S)-2,2,2-trifluoro-1-methylethyl]-
CBNumber
CB38153637
Molecular Formula
C22H21F4N5O3
Formula Weight
479.43
MOL File
2101700-15-4.mol
More
Less

Pirtobrutinib Property

Boiling point:
619.2±55.0 °C(Predicted)
Density 
1.44±0.1 g/cm3(Predicted)
storage temp. 
4°C, stored under nitrogen
solubility 
DMSO : 50 mg/mL (104.29 mM; Need ultrasonic)
form 
A solid
pka
13.32±0.46(Predicted)
color 
White to yellow
InChIKey
FWZAWAUZXYCBKZ-NSHDSACASA-N
SMILES
N1([C@@H](C)C(F)(F)F)C(N)=C(C(N)=O)C(C2=CC=C(CNC(=O)C3=CC(F)=CC=C3OC)C=C2)=N1
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H360May damage fertility or the unborn child

H373May cause damage to organs through prolonged or repeated exposure

Precautionary statements

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P314Get medical advice/attention if you feel unwell.

P501Dispose of contents/container to..…

More
Less

Pirtobrutinib Chemical Properties,Usage,Production

Description

Pirtobrutinib, or LOXO-305 and LY 3527727, is a Bruton's tyrosine kinase (BTK) inhibitor and antineoplastic agent. Pirtobrutinib showed promising initial efficacy in pts with pretreated Richter transformation with extremely poor prognosis, including in patients who had received prior chemoimmunotherapy and covalent BTK inhibitors. Pirtobrutinib is a highly selective and potent non-covalent BTK inhibitor (BTKi) with high oral bioavailability and a long half-life, resulting in robust BTK target coverage even in high-grade malignancies with high BTK protein turnover.

Uses

Pirtobrutinib (LOXO-305), a highly selective and non-covalent next generation BTK inhibitor, inhibits diverse BTK C481 substitution mutations. Pirtobrutinib causes regression of BTK-dependent lymphoma tumors in mouse xenograft models. Pirtobrutinib is also more than 300-fold selective for BTK versus 370 other kinases tested and shows no significant inhibition of non-kinase off-targets at 1 μM[1].

References

[1] Gomez E B , et al. Loxo-305, a Highly Selective and Non-Covalent Next Generation BTK Inhibitor, Inhibits Diverse BTK C481 Substitution Mutations[J]. Blood, 2019, 134(Supplement_1):4644-4644.

Pirtobrutinib Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Pirtobrutinib Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81

2101700-15-4, PirtobrutinibRelated Search:


  • 1H-Pyrazole-4-carboxamide, 5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(1S)-2,2,2-trifluoro-1-methylethyl]-
  • (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide
  • Pirtobrutinib
  • Pirtobrutinib (LOXO-305)
  • LY 3527727
  • loxo-305
  • (S)-5-Amino-3-{4-[(5-fluoro-2-methoxy-benzoylamino)-methyl]-phenyl}-1-(2,2,2-trifluoro-1-methyl-ethyl)-1H-pyrazole-4-carboxylic acid amide
  • LOXO 305,inhibit,LOXO-305,Btk,Pirtobrutinib,C81S,LOXO305,Bruton tyrosine kinase,proliferative,Inhibitor,mutations,autophosphorylation
  • LOXO-305,LY 3527727,Pirtobrutinib
  • BTK inhibitor 16
  • Florfenicol Impurity 16
  • [2,4,6-tribromo-thiophenol, Benzenethiol-2,4,6-tribromide, benzenethiol 2,4,6-tribromine, 2.4.6-Tribrom-phenylmercaptan, 2,4,6-tribromo benzenethiol, 2.4.6-Tribrom-1-mercapto-benzol, 2,4,6-Tribrom-thi
  • Pirtobrutinib, 10 mM in DMSO
  • 2101700-15-4
  • api
  • Pirtobrutinib